BioSig Technologies, Inc. STEX Corporate — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s corporate — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s corporate — D&A?
- BioSig Technologies, Inc. (STEX) reported corporate — D&A of $1.49M in Q1 2026.
- How has BioSig Technologies, Inc.'s corporate — D&A changed year-over-year?
- BioSig Technologies, Inc.'s corporate — D&A increased by 7004.8% year-over-year, from $21K to $1.49M.
- What does corporate — D&A mean?
- Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the corporate segment. It provides insight into the capital intensity of the business and the ongoing investment in infrastructure.